Kalshi to offer betting on drug trial results and FDA regulatory decisions

The Guardian reports that Kalshi, a prediction platform, is expanding into pharmaceutical betting. The service will offer wagers on drug trial outcomes and FDA regulatory decisions. Kalshi says this would surface trial data companies typically keep quiet and generate probabilities based on evidence rather than on sponsors' preferred narratives.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton